Challenges of empirical antibiotic therapy for community-acquired pneumonia in children
<h4>Background</h4> <p>Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality globally, responsible for more than 14% of deaths in children younger than 5 years of age. Due to difficulties with pathogen identification and diagnostics of CAP in children, t...
| Autore principale: | |
|---|---|
| Natura: | Journal article |
| Pubblicazione: |
Elsevier
2017
|